Technology | February 06, 2007

Thrombectomy System Features Faster Setup


The new AngioJet Ultra Thrombectomy System is a next-generation, completely re-engineered version of Possis' AngioJet Rheolytic Thrombectomy System. AngioJet is marketed for blood clot removal (thrombectomy) from arterial and venous blood vessels. The new Ultra System features a faster setup process, the flexibility to use a broad range of catheters, a sleeker design, lighter weight and handling improvements that make it easier to maneuver than the previous AngioJet drive unit.

According to the company, Ultra features an advanced control system with easier, more intuitive commands. Ultra also allows the physician to switch to Possis' patented Power Pulse delivery when necessary, simultaneously delivering clot-dissolving drugs while removing blockages from the affected arteries and veins.


Additional Content

News | Thrombectomy Devices

Oct.19, 2026 – Jupiter Endovascular has announced publication of full results from its SPIRARE II pivotal trial ...

Home October 20, 2026
Home
News | Thrombectomy Devices

Oct. 12, 2026 — Endovascular Engineering (E2) has announced that the U.S. Food and Drug Administration (FDA) has granted ...

Home October 13, 2026
Home
News | Thrombectomy Devices

Sept. 8, 2026 — Penumbra recently launched the Link clot capture device designed to support the removal of arterial ...

Home September 15, 2026
Home
News | Thrombectomy Devices

Aug. 29, 2026— Vesalio recently announced results from the NATURE trial (NCT04969471), a prospective, randomized ...

Home September 10, 2026
Home
News | Thrombectomy Devices

July 21, 2026 — Vesalio recently announced that the results from the randomized NATURE clinical trial evaluating the ...

Home July 21, 2026
Home
Subscribe Now